Welcome to CDC Stacks | Immune Response of Hepatitis B Vaccine Among Persons With Diabetes - 21376 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Immune Response of Hepatitis B Vaccine Among Persons With Diabetes
  • Published Date:
    Dec 2012
  • Source:
    Diabetes Care. 2012; 35(12):2690-2697.
Filetype[PDF - 796.62 KB]


No Related Documents.
You May Also Like:
  1. Low Immune Response to Hepatitis B Vaccine among Children in Dakar, Senegal
    Personal Author:
    Rey-Cuille, Marie-Anne; Seck, Abdoulaye; Njouom, Richard; Chartier, Loïc; Sow, Housseyn Dembel; Mamadou, ; Ka, Amadou Sidy; Njankouo, Mohamadou; Rousset, Dominique; Giles-Vernick, Tamara; Unal, Guillemette; Sire, Jean-Marie; Garin, Benoît; Simon, François; Vray, Muriel;
    Published:
    May 30 2012
    Source:
    PLoS One. 2012; 7(5).
    Description:
    HBV vaccine was introduced into the Expanded Programme on Immunization (EPI) in Senegal and Cameroon in 2005. We conducted a cross-sectional study in both countries to assess the HBV immune protection among children. All consecutive children under 4 ...
    File Type:
    Filetype[PDF - 92.92 KB]
  2. Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities☆
    Personal Author:
    Tohme, Rania A.; Awosika-Olumo, Debo; Nielsen, Carrie; Khuwaja, Salma; Scott, Jennifer; Xing, Jian; Drobeniuc, Jan; Hu, Dale J.; Turner, Cynthia; Wafeeg, Toni; Sharapov, Umid; Spradling, Philip R.;
    Published:
    Oct 18 2011
    Source:
    Vaccine. 29(50):9316-9320.
    Description:
    Background : During the past decade, in the United States, an increasing number of hepatitis B outbreaks have been reported in assisted living facilities (ALFs) as a result of breaches in infection control practices. We evaluated the seroprotection r...
    File Type:
    Filetype[PDF - 607.21 KB]
  3. Lack of Interference by Zoster Vaccine With the Immune Response to Yellow Fever Vaccine
    Personal Author:
    Stier, David M.; Weber, Ingrid B.; Staples, J. Erin;
    Published:
    2012 Mar-Apr
    Source:
    J Travel Med. 19(2):122-123.
    Description:
    Concerns exist about the serologic response to yellow fever (YF) vaccine when given within 28 days of another live virus vaccine. We report the case of a healthy adult who received 17D YF vaccine 21 days following administration of another live viral...
    File Type:
    Filetype[PDF - 41.14 KB]
  4. Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes
    Personal Author:
    Hoerger, Thomas J.; Schillie, Sarah F.; Wittenborn, John S.; Bradley, Christina L.; Zhou, Fangjun; Byrd, Kathy; Murphy, Trudy V.;
    Published:
    Aug 28 2012
    Source:
    Diabetes Care. 2013; 36(1):63-69.
    Description:
    OBJECTIVE : To examine the cost-effectiveness of a hepatitis B vaccination program for unvaccinated adults with diagnosed diabetes in the U.S. : RESEARCH DESIGN AND METHODS : We used a cost-effectiveness simulation model to estimate the cost-effectiv...
    File Type:
    Filetype[PDF - 322.99 KB]
  5. Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection
    Corporate Author:
    Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2008; 57(RR-8):1-20.
    Description:
    Routine vaccination of children is an effective way to reduce hepatitis A incidence in the United States. Since licensure of hepatitis A vaccine during 1995-1996, the hepatitis A childhood immunization strategy has been implemented incrementally, sta...
    Status:
    current
    File Type:
    Filetype[PDF - 474.67 KB]